Ignite Creation Date:
2024-05-06 @ 9:54 AM
Last Modification Date:
2024-10-26 @ 12:21 PM
Study NCT ID:
NCT03107988
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-02-09
First Post:
2017-03-21
Brief Title:
NANT 2015-02 A Phase 1 Study of Lorlatinib PF-06463922
Sponsor:
New Approaches to Neuroblastoma Therapy Consortium
Organization:
New Approaches to Neuroblastoma Therapy Consortium
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neuroblastoma |
Keywords: